Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease
Recruiting · NCT07474220 · Observational (researchers observe without assigning treatment) · Lead sponsor: Fu Jen Catholic University
View the official record on ClinicalTrials.gov →What this trial is about
This study aims to investigate the expression level of SLC25A48, a mitochondrial choline transporter, in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease, and to analyze its correlation with inflammatory markers and choline metabolic byproducts.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- pre-COPD or COPD stages I-IV as per the 2023 GOLD guidelines (case group)
- healthy individuals without chronic diseases or major medical conditions
Exclusion criteria
- diagnosed with neuromuscular diseases
- experienced respiratory disease exacerbation requiring emergency care or hospitalization in the past three months
- assessed by a physician to have severe malnutrition or a significantly low BMI
- continuously taking folic acid supplements
- willing to receive or have already received self-paid nutrition clinic services at this hospital
Where it is running
2 locations listed.
- Cardinal Tien Hospital - New Taipei City, Taiwan
- Fu Jen Catholic University Hospital, Fu Jen Catholic University - New Taipei City, Taiwan